Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1982-1987

  Tarantino Jr , Paul M ^a,b   Zhi, Chengxin ^a   Wright, George E ^a,b   Brown, Neal C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b GLSYNTHESIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE GAMMA; ENZYME INHIBITOR; URACIL DERIVATIVE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME INHIBITION; GRAM POSITIVE BACTERIUM; INTRAPERITONEAL DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

EID: 0032867111     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1982     Document Type: Article

References (26)

1. Barnes, M. H., and N. C. Brown. 1979. Antibody to B. subtilis DNA polymerase III: use in the purification of enzyme and the study of its structure. Nucleic Acids Res. 6:1203-1219.
2. Barnes, M. H., C. Leo, and N. C. Brown. 1998. DNA polymerase III of gram-positive eubacteria is a zinc metalloprotein conserving an essential finger-like domain. Biochemistry 37:15254-15260.
3. Barnes, M. H., P. M. Tarantino, P. Spacciapoli, H. Yu, N. C. Brown, and K. Dybvig. 1994. DNA polymerase III of Mycoplasma pulmonis: isolation and characterization of the enzyme and its structural gene, polC. Mol. Microbiol. 13:843-854.
4. Brown, N. C. Unpublished data.
5. Brown, N. C., L. W. Dudycz, and G. E. Wright. 1986. Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. Drugs Exp. Clin. Res. 12:555-564.
6. Brown, N. C., and R. E. Handschumacher. 1966. Inhibition of the synthesis of deoxyribonucleic acid in bacteria by 6-(p-hydroxyphenylazo)-2,4-dihydroxypyrimidine: metabolic studies in Streptococcus faecalis. J. Biol. Chem. 241:3083-3089.
7. Brown, N. C., J. J. Gambino, and G. E. Wright. 1977. Inhibitors of Bacillus subtilis DNA polymerase III. 6-(Arylalkylamino)uracils and 6-anilinouracils. J. Med. Chem. 20:1186-1189.
8. 2-(3,4-dichlorobenzyl)guanine. Nucleic Acids Res. 18:7381-7387.
9. Clements, J. E., J. D'Ambrosio, and N. C. Brown. 1975. Inhibition of Bacillus subtilis DNA polymerase III by phenylhydrazinopyrimidines: demonstration of a drug-induced DNA:enzyme complex. J. Biol. Chem. 250:522-526.
10. Cozzarelli, N. R. 1977. The mechanism of action of inhibitors of DNA synthesis. Annu. Rev. Biochem. 46:641-668.
11. Flett, F., D. Jungmann-Campello, V. Mersinias, S. Koh, R. Godden, and C. Smith. 1999. A 'Gram-negative type' DNA polymerase III is essential for replication of the linear chromosome of Streptomyces coelicolor A3(2). Mol. Microbiol. 31:949-958.
12. Hammond, R. A., and N. C. Brown. 1992. Overproduction and purification of Bacillus subtilis DNA polymerase III. Protein Expr. Purif. 3:65-70.
13. Huang, Y.-P., and J. Ito. 1998. The hyperthermophilic bacterium Thermotoga maritima has two different classes of family C DNA polymerases: evolutionary implications. Nucleic Acids Res. 26:5300-5309.
14. Kim, D. R., and C. S. McHenry. 1996. In vivo assembly of overproduced DNA polymerase III. J. Biol. Chem. 271:20681-20689.
15. Kornberg, A., and T. Baker. 1992. DNA replication. W. H. Freeman & Co., New York, N.Y.
16. Love, E., J. D'Ambrosio, D. Dubnau, and N. C. Brown. 1976. Mapping of the gene specifying DNA polymerase III of Bacillus subtilis. Mol. Gen. Genet. 144:313-321.
17. Mackenzie, J. M., M. N. Neville, G. E. Wright, and N. C. Brown. 1973. Hydroxyphenylazopyrimidines: characterization of the active forms and their inhibitory action on a DNA polymerase from Bacillus subtilis. Proc. Natl. Acad. Sci. USA 70:512-516.
18. Pacitti, D. F., M. H. Barnes, D. H. Li, and N. C. Brown. 1995. Characterization and expression of Staphylococcus aureus polC, the structural gene for DNA polymerase III. Gene 165:51-56.
19. Tarantino, P. M., C. Zhi, J. J. Gambino, G. E. Wright, and N. C. Brown. 1999. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N-3. J. Med. Chem. 42:2035-2040.
20. Tomasz, A. 1994. Multiple-antibiotic-resistant pathogenic bacteria. N. Engl. J. Med. 330:1247-1251.
21. Trantolo, D. J., G. E. Wright, and N. C. Brown. 1986. Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino-and (benzylamino)uracils. J. Med. Chem. 29:676-681.
22. Wolfson, J. S., and D. C. Hooper. 1989. Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 2:378-424.
23. Wright, G. E., and N. C. Brown. 1976. The mechanism of inhibition of B. subtilis DNA polymerase III by 6-(arylhydrazino)pyrimidines: novel properties of 2-thiouracil derivatives. Biochim. Biophys. Acta 432:37-48.
24. Wright, G. E., and N. C. Brown. 1980. Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. J. Med. Chem. 23:34-38.
25. Wright, G. E., and N. C. Brown. 1990. Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. Pharmacol. Ther. 47:447-497.
26. Wright, G. E., and J. J. Gambino. 1984. Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III. J. Med. Chem. 27:181-185.